AFP and hepatocellular carcinoma: AFP-L3 has shown to be a highly specific biomarker for HCC, allowing to differentiate HCC from cirrhosis, and also serves as a predictive marker for the development of HCC during the follow-up of patients with cirrhosis [28, 30, 31].